[INFOGRAPHIC] Making Effective Use of Adaptive Designs in Early Oncology Trials
Adaptive Designs provide greater efficiency and flexibility for Investigators/pharmaceutical companies by minimizing the number of patients in each development phase and reducing the time needed for the whole process. Study design is early phases is extremely important. Safety and efficacy, ethical considerations and long patient recruitment all need to be taken into account.